ClinicalTrials.Veeva

Menu

Pharmacokinetics of HCP1305 and Co-administration of HCP0605, HGP0816 in Healthy Male Volunteers

Hanmi Pharmaceutical logo

Hanmi Pharmaceutical

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Drug: HCP1305
Drug: HCP0605 + HGP0816

Study type

Interventional

Funder types

Industry

Identifiers

NCT04039724
HM-ALRO-102

Details and patient eligibility

About

To investigate the pharmacokinetics and safety/tolerability after administration of HCP1305 and co-administration of HCP0605, HGP0816 in healthy male volunteers

Full description

The purpose of this study is to investigate the pharmacokinetics and safety/tolerability after administration of HCP1305 and co-administration of HCP0605, HGP0816 in healthy male volunteers

Enrollment

61 patients

Sex

Male

Ages

19 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Healthy male volunteer, age 19~45 years
  2. Weight is not less than 55kg, no more than 90kg and Body Mass Index(BMI) is not less than 18 kg/m2 , no more than 27 kg/m2
  3. Subjects who have ability to comprehend the objectives, contents of study and property of study drug before participating in trial and have willingness to sign of informed consent in writing

Exclusion criteria

  1. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
  2. Subjects who judged ineligible by the investigator.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

61 participants in 2 patient groups

Sequence A
Experimental group
Description:
Period 1 : HCP0605+HGP0816 Period 2 : HCP1305
Treatment:
Drug: HCP1305
Drug: HCP0605 + HGP0816
Sequence B
Experimental group
Description:
Period 1 : HCP1305 Period 2 : HCP0605+HGP0816
Treatment:
Drug: HCP1305
Drug: HCP0605 + HGP0816

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems